PortfoliosLab logoPortfoliosLab logo
MURA vs. IRON
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

MURA vs. IRON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mural Oncology plc (MURA) and Disc Medicine Inc. (IRON). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MURA vs. IRON - Yearly Performance Comparison


2026 (YTD)202520242023
MURA
Mural Oncology plc
0.00%-36.65%-45.61%55.79%
IRON
Disc Medicine Inc.
-19.48%25.25%9.76%19.44%

Fundamentals

Market Cap

MURA:

$35.34M

IRON:

$2.26B

EPS

MURA:

-$6.89

IRON:

-$6.03

PB Ratio

MURA:

0.64

IRON:

3.05

Total Revenue (TTM)

MURA:

$0.00

IRON:

-$19.88M

Gross Profit (TTM)

MURA:

-$1.10M

IRON:

-$12.65M

EBITDA (TTM)

MURA:

-$118.31M

IRON:

-$236.02M

Returns By Period


MURA

1D
0.00%
1M
0.00%
YTD
0.00%
6M
-1.45%
1Y
61.90%
3Y*
5Y*
10Y*

IRON

1D
5.20%
1M
-4.02%
YTD
-19.48%
6M
-3.24%
1Y
28.81%
3Y*
44.50%
5Y*
-13.57%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Mural Oncology plc

Disc Medicine Inc.

Return for Risk

MURA vs. IRON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MURA
MURA Risk / Return Rank: 5959
Overall Rank
MURA Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
MURA Sortino Ratio Rank: 9696
Sortino Ratio Rank
MURA Omega Ratio Rank: 9898
Omega Ratio Rank
MURA Calmar Ratio Rank: 2020
Calmar Ratio Rank
MURA Martin Ratio Rank: 2323
Martin Ratio Rank

IRON
IRON Risk / Return Rank: 5757
Overall Rank
IRON Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
IRON Sortino Ratio Rank: 5656
Sortino Ratio Rank
IRON Omega Ratio Rank: 5858
Omega Ratio Rank
IRON Calmar Ratio Rank: 5454
Calmar Ratio Rank
IRON Martin Ratio Rank: 5656
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MURA vs. IRON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mural Oncology plc (MURA) and Disc Medicine Inc. (IRON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MURAIRONDifference

Sharpe ratio

Return per unit of total volatility

0.52

0.47

+0.04

Sortino ratio

Return per unit of downside risk

3.71

1.04

+2.68

Omega ratio

Gain probability vs. loss probability

1.68

1.15

+0.53

Calmar ratio

Return relative to maximum drawdown

-0.62

0.55

-1.16

Martin ratio

Return relative to average drawdown

-0.99

1.48

-2.48

MURA vs. IRON - Sharpe Ratio Comparison

The current MURA Sharpe Ratio is 0.52, which is comparable to the IRON Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of MURA and IRON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MURAIRONDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.52

0.47

+0.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

-0.12

-0.10

Correlation

The correlation between MURA and IRON is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MURA vs. IRON - Dividend Comparison

Neither MURA nor IRON has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MURA vs. IRON - Drawdown Comparison

The maximum MURA drawdown since its inception was -83.44%, smaller than the maximum IRON drawdown of -93.22%. Use the drawdown chart below to compare losses from any high point for MURA and IRON.


Loading graphics...

Drawdown Indicators


MURAIRONDifference

Max Drawdown

Largest peak-to-trough decline

-83.44%

-93.22%

+9.78%

Max Drawdown (1Y)

Largest decline over 1 year

-47.99%

-40.55%

-7.44%

Max Drawdown (5Y)

Largest decline over 5 years

-91.30%

Current Drawdown

Current decline from peak

-66.06%

-64.48%

-1.58%

Average Drawdown

Average peak-to-trough decline

-46.21%

-66.62%

+20.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

48.22%

14.93%

+33.29%

Volatility

MURA vs. IRON - Volatility Comparison

The current volatility for Mural Oncology plc (MURA) is 0.00%, while Disc Medicine Inc. (IRON) has a volatility of 14.62%. This indicates that MURA experiences smaller price fluctuations and is considered to be less risky than IRON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MURAIRONDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

14.62%

-14.62%

Volatility (6M)

Calculated over the trailing 6-month period

31.67%

47.93%

-16.26%

Volatility (1Y)

Calculated over the trailing 1-year period

155.23%

61.21%

+94.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

117.07%

72.60%

+44.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

117.07%

70.40%

+46.67%

Financials

MURA vs. IRON - Financials Comparison

This section allows you to compare key financial metrics between Mural Oncology plc and Disc Medicine Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-20.00M-15.00M-10.00M-5.00M0.00JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
-19.88M
(MURA) Total Revenue
(IRON) Total Revenue
Values in USD except per share items